CAS RN: 50700-72-6
Vecuronium Bromide
Product Availability
Choose a grade to view its available package options.
6 package records6 with current stock1 grade group
| Batch No. | Package | Availability | Warehouse | Inquiry |
| Batchno.20260419 |
10mg |
In stock |
Shanghai | Inquiry |
| Batchno.20260612 |
1g |
In stock |
Shanghai | Inquiry |
| Batchno.20250924 |
1mg |
In stock |
Shanghai | Inquiry |
| Batchno.20250906 |
250mg |
In stock |
Shanghai | Inquiry |
| Batchno.20250601 |
50mg |
In stock |
Shanghai, Tianjin | Inquiry |
| Batchno.20250514 |
5g |
In stock |
Shanghai | Inquiry |
-
Product code:
ICTV0120
-
Purity/Analytical Methods:
>98.0%(T)(HPLC)
GET A QUOTE
50700-72-6 / [(2S,3S,5S,8R,9S,10S,13S,14S,16S,17R)-17-acetyloxy-10,13-dimethyl-16-(1-methylpiperidin-1-ium-1-yl)-2-piperidin-1-yl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yl] acetate bromide
Standard CAS: 50700-72-6
Multi CAS: Yes
Basic Information
CAS
50700-72-6
Multi CAS
Yes
Molecular Formula
BC34H57O4Rn2
Molecular Weight
637.700000
Exact Mass
636.350170
InChI
InChI=1S/C34H57N2O4.BrH/c1-23(37)39-31-20-25-12-13-26-27(34(25,4)22-29(31)35-16-8-6-9-17-35)14-15-33(3)28(26)21-30(32(33)40-24(2)38)36(5)18-10-7-11-19-36;/h25-32H,6-22H2,1-5H3;1H/q+1;/p-1/t25-,26+,27-,28-,29-,30-,31-,32-,33-,34-;/m0./s1
InChIKey
VEPSYABRBFXYIB-PWXDFCLTSA-M
Computed Properties
Structural Parameters
Heavy atom count
41
Fraction Csp3
0.94
Rotatable bonds
4
H-bond acceptors
5
Molar refractivity
156.37
TPSA
55.84
LogP / Solubility
WLOGP
2.97
MLOGP
2.67
XLogP3
2.97
Consensus LogP
2.87
Log S (ESOL)
-5.4
Class (ESOL)
Slightly soluble
Log S (Ali)
-6.93
Class (Ali)
Insoluble
Log S (SILICOS-IT)
-6.75
Class (SILICOS-IT)
Insoluble
ADME
GI absorption
High
BBB permeant
Yes
P-gp substrate
No
CYP1A2 inhibitor
No
CYP2C19 inhibitor
No
CYP2C9 inhibitor
Yes
CYP2D6 inhibitor
Yes
CYP3A4 inhibitor
Yes
Log Kp (skin permeation)
-4.5
Drug-likeness / Medicinal Chemistry
Lipinski
Yes
Ghose
No
Veber
Yes
Egan
Yes
Muegge
No
Bioavailability score
0.55
Brenk alerts
1
Leadlikeness
No
Synthetic Accessibility
10